NMRA
Neumora Therapeutics, Inc.
0.6776$
-2.1%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | 97.9% | 96.8% | 91.0% | 96.4% | 99.1% | 99.7% | |
| – | 97.0% | 95.3% | 56.5% | 75.4% | 44.8% | 95.5% | |
| – | 97.0% | 95.3% | 87.2% | 91.5% | 97.0% | 95.5% | |
| – | 0.1% | 0.0% | 0.2% | 0.2% | – | – | |
| – | – | 0.0% | 0.0% | – | – | – | |
| – | 2.0% | 0.9% | 2.5% | – | – | – | |
| – | 147.7% | 175.8% | 204.8% | 5.5% | 9.4% | 45.6% | |
| – | 4.7% | 5.4% | 5.6% | 5.1% | 9.4% | 17.0% | |
| – | 0.4% | 0.2% | 0.8% | 0.7% | 0.6% | 0.1% | |
| – | 1.2% | 0.4% | 1.7% | 0.1% | 1.0% | 1.8% | |
| – | – | – | – | – | – | 28.5% | |
| – | -47.7% | -75.8% | -104.8% | 94.5% | 90.6% | 54.4% | |
| – | -50.2% | -78.4% | -109.7% | -141.8% | -298.8% | -619.8% | |
| – | 76.8% | 35.4% | 35.6% | 32.0% | 50.3% | 85.5% |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.